We showed that cytoplasmic REIC/DKK-3 interferes with the dimerization of SGTA and abolishes the function of SGTA as a negative regulator of the AR, resulting in enhanced AR sensitivity in human prostate cancer cells. The gene discussed is AR; the disease is prostate carcinoma.